Houlihan Lokey, Inc.
HLIHoulihan Lokey, Inc. is cheap for a reason. The P/BV sits at the 31st percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: annual EPS moved +6.9% against a −25.8% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (13 weeks in) while the P/BV sits at the 31st percentile of its own 5-year range. Underneath, the last four quarters read deteriorating — profit −16.7% year on year, with the the net margin at 15.6%. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Houlihan Lokey, Inc. trades at $145, in a downtrend and 13 weeks into that stage. That is −10.2% against its own 200-day average. It sits at 14% of a 52-week range of $135 to $209. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (43 weeks and counting).
Today the stock is in a downtrend — week 13 of stage 4. At $145 it trades −10.2% versus its 200-day average and sits at 14% of its 52-week range ($135–$209).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +567% while the S&P 500 moved +248% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (43 weeks and counting; last ahead the week of 2025-10-03) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/BV sits at the 31st percentile of its own range.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Houlihan Lokey, Inc. trades at 4.3× P/BV, near the bottom of its own range — cheaper only 31% of the time. Its long-run median P/BV is 4.7×, measured across 5.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 4.3× is near the bottom of its own range — cheaper only 31% of the time, against a long-run median of 4.7× measured over 5.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year book value grew while the price moved −25.8% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +10.3%/yr price move, ~+11.3%/yr came from book-value growth and ~−1.0 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Topping out Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Houlihan Lokey, Inc. reads as topping out on its fundamental arc. Topping out — revenue, profit and EPS growth have decelerated hard (revenue growth +23.4% at its peak → +10.5% latest) while ROE still reads 18.4%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: decelerating from a peak is where good stories quietly end — the multiple usually notices late.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +9.6% | +13.1% | — | — |
| Profit | +5.0% | +18.9% | — | — |
| EPS | +6.9% | +18.3% | — | — |
| Stock price | −25.8% | +13.6% | +10.3% | +20.3% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
33.0/100 — rank 21 of 27 in Capital Markets · 76% evidence confidence
Houlihan Lokey, Inc. scores 33.0 out of 100 against the 27 companies it is compared with in Capital Markets, ranking 21. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 9.3 + 13.7 + 5.3 + 4.7 = 33. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
Houlihan Lokey, Inc. reported $0.6 B of income in the Mar 26 quarter, −4.5% year on year. Over 4 years it has compounded at 3.6% a year. The last full year, FY26, came in at $2.6 B. The last four reported quarters add to $2.6 B.
Houlihan Lokey, Inc. reported $0.6 B of income in the Mar 26 quarter, −4.5% year on year. Over 4 years it has compounded at 3.6% a year. The last full year, FY26, came in at $2.6 B. The last four reported quarters add to $2.6 B.
FY26 revenue came in at $2.6 B (+9.6% on the year), capping 4 years at 3.6% compound. The latest quarter (Mar 26) printed $0.6 B, −4.5% year on year.
Pace check: the last four quarters averaged +11.3% growth against the decade's 3.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +10.5% over the last 4 quarters against +17.0%/yr over the last 8 — rolling over; TTM profit +7.5% vs +23.9%/yr — rolling over.
→ Revenue slipped — did the net margin hold as it scaled? Next: 15.6% this quarter (−2.3 pp YoY).
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
Houlihan Lokey, Inc.'s net margin is 15.6% in the Mar 26 quarter, −2.3 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 13.8% to 19.4%. The current quarter sits inside that band.
Houlihan Lokey, Inc.'s net margin is 15.6% in the Mar 26 quarter, −2.3 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 13.8% to 19.4%. The current quarter sits inside that band.
The latest quarter's net margin is 15.6%, −2.3 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 13.8%–19.4%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
→ The net margin slipped — did that reach the bottom line? Next: profit −16.7% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Houlihan Lokey, Inc. earned $0.1 B of net profit in the Mar 26 quarter, −16.7% year on year. Full-year FY26 profit was $0.4 B. The 4-year compound rate is −1.2%. That is 15.6% of the quarter's revenue. The same quarter a year earlier earned $0.1 B.
Houlihan Lokey, Inc. earned $0.1 B of net profit in the Mar 26 quarter, −16.7% year on year. Full-year FY26 profit was $0.4 B. The 4-year compound rate is −1.2%. That is 15.6% of the quarter's revenue. The same quarter a year earlier earned $0.1 B.
Mar 26 profit was $0.1 B, −16.7% year on year. On the full year, FY26 printed $0.4 B (+5.0%), and the 4-year compound rate is −1.2%.
🚨 Why profit moved: revenue contributed −4.5% and the margin −2.3 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +9.1% vs revenue +11.3%. Profit and revenue are moving roughly in step.
→ Profit is up — how clean is the loan book behind it? Next: we hold no quarterly loan-book numbers — the section says so plainly.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Houlihan Lokey, Inc., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
→ Behind the profits — is the book itself still growing? Next: revenue grew +9.6% in FY26.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Houlihan Lokey, Inc.'s revenue grew +9.6% in FY26 to $2.6 B, so the book is growing. The latest quarter ran −4.5% year on year. The net margin on that income is 15.6%, −2.3 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY26 revenue was $2.6 B, +9.6% on the year, and the latest quarter ran −4.5% year on year. The net margin on that revenue is 15.6% this quarter (−2.3 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
→ Does all of this actually earn its keep on equity? Next: ROE is 18%.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Houlihan Lokey, Inc. earns a return on equity of 18% in FY26. Its trough over the ladder below was 15% in FY24. On the asset side every $100 of the balance sheet earned about $10.44, which is the return before leverage is applied.
FY26 ROE came in at 18%, recovered from a FY24 trough of 15%. On assets, the latest reading is about 10.44% — every $100 the bank deploys earns roughly $10.44 a year. That clears the bar a bank must beat for its book value to compound.
Why ROE moved: profit compounded −1.2% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
→ Who owns this bank, and are they adding or leaving? Next: short interest is 3.3% of the float.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Houlihan Lokey, Inc. paid $2.40 per share over the last four reported quarters, up 5.3% on a year ago. The most recent declaration was $0.60 for Mar 26. Against the current price of $145 that is a trailing yield of 1.65%, measured on dividends already paid rather than on a forecast.
Houlihan Lokey, Inc. paid $2.40 per share over the last four reported quarters, up 5.3% on a year ago. The most recent declaration was $0.60 for Mar 26. Against the current price of $145 that is a trailing yield of 1.65%, measured on dividends already paid rather than on a forecast.
Houlihan Lokey, Inc. paid $2.40 per share across the last four reported quarters, most recently $0.60 for Mar 26. That is up 5.3% against the same quarter a year earlier. Against the current price of $145 the trailing twelve months work out to 1.65% — trailing dividends measured against today's price, not a forward estimate.
→ A payout is cash leaving the business. Next: what the balance sheet looks like behind it.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
→ Who owns this, and are they adding or leaving? Next: short interest is 3.3% of the float.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
3.3% of Houlihan Lokey, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 1.9 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 3.3% of the float is sold short, and at typical trading volumes it would take about 1.9 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Houlihan Lokey, Inc.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
Frequently asked questions
What is Houlihan Lokey, Inc.'s stock price today?
Houlihan Lokey, Inc. trades at $145, −25.8% over the past year. The company is valued at $10.0 B. The stock sits at 14% of its 52-week range of $135–$209, −10.2% versus its 200-day average. On the tape, the price is in a downtrend, 13 weeks in. — as of 29 July 2026.
What were Houlihan Lokey, Inc.'s latest quarterly results?
Houlihan Lokey, Inc. reported total income of $0.6 B and net profit of $0.1 B for the Mar 26 quarter. Income fell 4.5% and profit fell 16.7% year on year. Earnings per share were $1.47. The net margin was 15.6%, 2.3 pp lower than a year earlier. — as of 29 July 2026.
What is Houlihan Lokey, Inc.'s revenue?
Houlihan Lokey, Inc. reported revenue of $0.6 B in the Mar 26 quarter, −4.5% year on year. For the full FY26 fiscal year, revenue was $2.6 B (+9.6%). Over the last 4 years revenue compounded at 3.6% a year. — as of 29 July 2026.
What is Houlihan Lokey, Inc.'s profit?
Houlihan Lokey, Inc. earned $0.1 B of net profit in the Mar 26 quarter, −16.7% year on year. Full-year FY26 profit was $0.4 B. The net margin ran 15.6% in the latest quarter. — as of 29 July 2026.
What is Houlihan Lokey, Inc.'s market cap?
Houlihan Lokey, Inc.'s market capitalisation is $10.0 B at a stock price of $145. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 29 July 2026.
What is Houlihan Lokey, Inc.'s P/BV ratio?
Houlihan Lokey, Inc. trades at a P/BV of 4.3×, at the 31st percentile of its own 5-year range, against a long-run median of 4.7×. This is a comparison with the stock's own history, not a value call — as of 29 July 2026.
Does Houlihan Lokey, Inc. pay a dividend?
Yes — Houlihan Lokey, Inc. declared $0.60 per share for Mar 26, and $2.40 per share across the last four reported quarters. The latest quarter is up 5.3% on the same quarter a year earlier. — as of 29 July 2026.
What is Houlihan Lokey, Inc.'s dividend per share?
Houlihan Lokey, Inc.'s most recently declared dividend is $0.60 per share for Mar 26, giving $2.40 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 29 July 2026.
What is Houlihan Lokey, Inc.'s dividend yield?
Houlihan Lokey, Inc.'s trailing dividend yield is 1.65%: $2.40 declared per share across the last four reported quarters, against a share price of $145. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 29 July 2026.
Is Houlihan Lokey, Inc. overvalued?
On its own history, Houlihan Lokey, Inc. looks cheap against its own history: its P/BV of 4.3× has been cheaper only 31% of the time in 5 years (long-run median 4.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 29 July 2026.
Is Houlihan Lokey, Inc. growing?
Not right now — Houlihan Lokey, Inc.'s latest numbers are shrinking: latest-quarter revenue −4.5% year on year, profit −16.7%, and the the net margin −2.3 pp at 15.6%. The 4-year compound rates are 3.6% (revenue) and −1.2% (profit). The earnings engine currently reads: deteriorating — as of 29 July 2026.
How is Houlihan Lokey, Inc. performing?
Houlihan Lokey, Inc. is in a downtrend, 13 weeks in. Its latest quarter's income fell 4.5% and profit fell 16.7% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 43 weeks. This describes what the data did, not a rating. — as of 29 July 2026.
What stage is Houlihan Lokey, Inc. in?
Topping out — revenue, profit and EPS growth have decelerated hard (revenue growth +23.4% at its peak → +10.5% latest) while ROE still reads 18.4%. The read comes from the last 12 quarters of growth (revenue growth +10.5% latest, profit growth +7.5% latest, eps growth +6.9% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 29 July 2026.
Is Houlihan Lokey, Inc. in an uptrend?
No — the price is in a downtrend (week 13 of stage 4), trading −10.2% versus its 200-day average and at 14% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 29 July 2026.
Is Houlihan Lokey, Inc. beating the market?
Not lately — on a trailing-13-week view Houlihan Lokey, Inc. is currently behind the S&P 500 (43 weeks and counting; last ahead the week of 2025-10-03), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +567% against the S&P 500's +248% — ahead of the index over the full window. — as of 29 July 2026.
Will Houlihan Lokey, Inc.'s stock price go up?
This page publishes no price forecast for Houlihan Lokey, Inc. What it measures instead: the stock price is $145, the price is in a downtrend 13 weeks in. Its P/BV of 4.3× sits at the 31st percentile of its own 5-year range. — as of 29 July 2026.
Is the market betting against Houlihan Lokey, Inc.?
Somewhat — short interest is 3.3% of Houlihan Lokey, Inc.'s tradable float, about 1.9 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 29 July 2026.
Is Houlihan Lokey, Inc.'s loan book healthy?
We do not hold quarterly loan-book quality numbers for Houlihan Lokey, Inc., so this page says that plainly. The cleanest available reads are revenue growth (+9.6% in FY26) and the net margin on it (15.6%) — as of 29 July 2026.
Where is Houlihan Lokey, Inc. in its business cycle?
Houlihan Lokey, Inc.'s FY26 net margin was 16.0%, against a 5-year band of 13.8%–19.4%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 15.6%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 29 July 2026.
What could break the Houlihan Lokey, Inc. story?
The sharpest disagreement: annual EPS moved +6.9% against a −25.8% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 29 July 2026.
Is Houlihan Lokey, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Houlihan Lokey, Inc. is cheap for a reason. The P/BV sits at the 31st percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 29 July 2026.